Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy Alone Repatha is Now the First and Only ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...

Both dosing regimens of amlitelimab were found to significantly improve skin clearance and disease severity. Topline results were announced from a phase 3 trial evaluating amlitelimab for the ...

Medtronic (NYSE: MDT) + announced today that a study of its Hugo surgical robot met primary safety and effectiveness endpoints. Results came from the company’s Enable Hernia Repair clinical study ...

Phase III results from Sanofi SA’s study of amlitelimab in treating atopic dermatitis met the primary and key secondary endpoints, but investors took a step back.

fEuropean Kidney Patients Federation, Federación Nacional ALCER, Madrid, Spain gEuropean Kidney Patients Federation, Nacional de Asociaciones ALCER & School of Psychology, Universidad Autónoma de ...

Source: Getty Images The FDA should ensure that drug approvals “are based on validated surrogate endpoints that have been proven to be strongly associated with improvements in clinical outcomes,” ...

AbbVie said a second late-stage study of its blockbuster autoimmune drug Rinvoq hit its main goals in the autoimmune disease alopecia areata. AbbVie on Thursday said the Phase 3 study evaluating the ...

AbbVie said a late-stage study of its blockbuster autoimmune drug Rinvoq hit its key goals in alopecia areata, an autoimmune disease that causes sudden hair loss. AbbVie on Wednesday said the Phase 3 ...